Published in Annu Rev Med on January 01, 1988
Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci U S A (1991) 1.58
Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann Rheum Dis (1992) 1.54
Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.07
Anticardiolipin antibody. BMJ (1989) 1.01
Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. Ann Rheum Dis (1988) 0.98
Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis. Clin Exp Immunol (1990) 0.97
Inhibitor(s) of natural anti-cardiolipin autoantibodies. Clin Exp Immunol (1993) 0.94
Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome. Postgrad Med J (1991) 0.93
Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J (1993) 0.86
Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A (1993) 0.82
A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1991) 0.77
Pathophysiology of the antiphospholipid antibody syndrome. Auto Immun Highlights (2011) 0.76
Antiphospholipid antibodies, thrombosis and vasculitis. Proceedings of a symposium. London, 16th December 1988. Postgrad Med J (1989) 0.75
A human monoclonal IgA autoantibody--185/12--behaves like an autoimmune antiphospholipid antibody. Clin Exp Immunol (1994) 0.75
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Systemic lupus erythematosus. Lancet (2001) 4.18
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
The catastrophic antiphospholipid syndrome. J Rheumatol (1992) 2.76
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
A "primary" antiphospholipid syndrome? J Rheumatol (1988) 1.77
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol (1989) 1.77
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76
Central nervous system lupus--diagnosis and treatment. J Rheumatol (1980) 1.75
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis (1989) 1.73
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis (1982) 1.64
Deficiency of factor B of the complement system in sickle cell anaemia. Br Med J (1976) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Hypoadrenalism, Addison's disease and antiphospholipid antibodies. J Rheumatol (1991) 1.60
Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60
Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum (1997) 1.58
Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum (1979) 1.57
Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol (1977) 1.57
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56
Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56
Significance of persisting serologic abnormalities in SLE. Arthritis Rheum (1976) 1.56
The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56
Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis (1983) 1.55
An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1979) 1.54
Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med (1984) 1.54
Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol (1998) 1.54
Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J (1985) 1.54
Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis (1982) 1.53
The anticardiolipin syndrome. Clin Exp Rheumatol (1986) 1.53
Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost (1997) 1.52
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. BMJ (1989) 1.52
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52
Rheumatoid arthritis and food: a case study. Br Med J (Clin Res Ed) (1981) 1.52
Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med (1984) 1.52
A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol (1991) 1.51
Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50
Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed) (1982) 1.50
The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol (1984) 1.48
Systemic lupus erythematosus in childhood. Ann Rheum Dis (1981) 1.48
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45
Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum (1982) 1.45
Clinical and immunologic features of livedo reticularis in lupus: a case-control study. Am J Med (1989) 1.44
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol (1996) 1.44
Current transport of leatherback sea turtles (Dermochelys coriacea) in the ocean. Proc Biol Sci (2003) 1.44
Systemic lupus erythematosus: two patients treated with danazol. Br Med J (Clin Res Ed) (1982) 1.43
Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS) Br J Rheumatol (1993) 1.42
Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost (2001) 1.41
Systemic lupus erythematosus: treatment and prognosis. Br Med J (1979) 1.41
Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system. Lupus (1997) 1.40
Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. J Rheumatol (1993) 1.39
Cutaneous photosensitivity in dermatomyositis. Br J Dermatol (1994) 1.38
Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol (1992) 1.38
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1987) 1.38
Lupus patients are protected from cancer. Lupus (2001) 1.37